A detailed history of Qube Research & Technologies LTD transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 62,026 shares of KPTI stock, worth $52,101. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,026
Previous 106,470 41.74%
Holding current value
$52,101
Previous $92,000 44.57%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.7 - $1.06 $31,110 - $47,110
-44,444 Reduced 41.74%
62,026 $51,000
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.58 $92,628 - $168,222
106,470 New
106,470 $92,000
Q2 2023

Aug 14, 2023

BUY
$1.79 - $4.59 $1.26 Million - $3.23 Million
703,062 New
703,062 $1.26 Million
Q4 2022

Feb 14, 2023

BUY
$2.48 - $5.93 $1.3 Million - $3.11 Million
523,788 New
523,788 $1.78 Million
Q2 2022

Aug 15, 2022

BUY
$4.15 - $8.37 $1.01 Million - $2.03 Million
242,997 New
242,997 $1.1 Million
Q2 2021

Aug 13, 2021

SELL
$8.11 - $11.11 $1.19 Million - $1.63 Million
-146,442 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$9.85 - $17.69 $542,774 - $974,789
55,104 Added 60.33%
146,442 $1.54 Million
Q4 2020

Feb 16, 2021

BUY
$14.15 - $17.19 $833,534 - $1.01 Million
58,907 Added 181.64%
91,338 $1.41 Million
Q3 2020

Nov 12, 2020

BUY
$14.14 - $19.71 $458,574 - $639,215
32,431 New
32,431 $473,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $67M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.